New-onset hyperglycaemia and prolonged systemic corticosteroids therapy in mild COVID-19 patients as major risk factors for invasive mucormycosis: a preliminary study

• Main Authors: Satyendra Khichar (Author), Subhashree Samantaray (Author), Deepak Kumar (Author), Veena Mobarsa (Author), Vidhi Jain (Author), Vidhu Sharma (Author), Kapil Soni (Author), Bikram Choudhary (Author), Amit Goyal (Author), Durga Meena (Author), Srikanth Srinivasan (Author), Naveen Dutt (Author), Pankaj Bhardwaj (Author), Ashwini Agarwal (Author), Mahendra Garg (Author), Sanjeev Misra (Author)
• Format: Book
• Published: Mazandaran University of Medical Sciences, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and Purpose: Rapid surge of invasive mucormycosis has surprised the Indian healthcare system amidst the coronavirus disease-19 (COVID-19) pandemic. Hence, there is an urgent need to find the risk factors for the sudden rise in cases of invasive mucormycosis among COVID-19 patients. This s...